Grass sickness, also known as equine dysautonomia, is a devastating and often fatal disease affecting the autonomic nervous system of horses, ponies, and donkeys. The condition causes degeneration of neurons throughout the autonomic and enteric nervous systems, leading to widespread dysfunction of the gastrointestinal tract and other body systems controlled by autonomic nerves. First identified in Scotland in the early 1900s, grass sickness remains one of the most serious and poorly understood equine diseases, with the majority of cases occurring in Great Britain and northern European countries, though cases have been reported worldwide.
The disease primarily affects horses with access to pasture, hence its common name, and shows striking geographical and seasonal patterns that suggest environmental triggers play a crucial role in its development. Peak incidence occurs during spring and early summer months when grass is actively growing, though cases can occur at any time of year. Certain pastures become known as high-risk areas where multiple cases occur over time, while neighboring fields may never produce a case. This geographical clustering has driven extensive research into soil, pasture, and environmental factors that might contribute to disease development.
Grass sickness has profound impacts on affected horses, with the disease classified into three forms based on duration and severity of clinical signs. Acute grass sickness progresses rapidly over hours to days and is invariably fatal. Subacute cases develop over several days to weeks and carry extremely high mortality despite treatment attempts. Chronic grass sickness develops more slowly and represents the only form where survival is possible with intensive nursing care, though even these cases have guarded prognosis. The devastating nature of this disease, combined with its relatively common occurrence in endemic areas, makes it one of the most feared conditions among horse owners in affected regions.
Despite decades of research, grass sickness remains poorly understood and no effective prevention or cure exists. Current evidence points toward the soil bacterium Clostridium botulinum and its toxins as the most likely causative agent, though the exact mechanism remains unclear. The lack of specific treatment means that supportive care and intensive nursing are the only options for affected horses, with the majority of cases resulting in death or euthanasia. Research continues to seek better understanding of disease mechanisms, risk factors, and potential preventive strategies that could reduce the devastating toll this disease takes on the equine population.
